Pathogenic specificity of effector T lymphocytes in syngeneic graft-versus-host disease

By Thoburn C.   Chen W.   Horwitz L.   Hess A.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 684-686

Elsevier

Access to resources Recommend Favorite

Combination Therapy with a CD4-CDR3 Peptide Analog and Cyclosporin A to Prevent Graft-vs-Host Disease in a MHC-Haploidentical Bone Marrow Transplantation Model

By Townsend R.M.   Gilbert M.J.   Korngold R.  

Clinical Immunology, Vol. 86, Iss. 1, 1998-01 ,pp. : 115-119

Academic Press

Access to resources Recommend Favorite

Characterization of the V /V Autoreactive T-Cell Repertoire in Syngeneic Graft-vs-Host Disease

By Hess A.   Ruvolo P.   Fischer A.   Horwitz L.   Bright E.   Thoburn C.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 709-711

Elsevier

Access to resources Recommend Favorite

The functional role of class II-associated invariant chain peptide (CLIP) in its ability to variably modulate immune responses

By Chaturvedi P.   Hengeveld R.   Zechel M.A.   Lee-Chan E.   Singh B.  

International Immunology, Vol. 12, Iss. 6, 2000-06 ,pp. : 757-765

Oxford University Press

Access to resources Recommend Favorite

Antigen presentation in graft-vs-host disease

By Shlomchik W.D.  

Experimental Hematology, Vol. 31, Iss. 12, 2003-12 ,pp. : 1187-1197

Elsevier

Access to resources Recommend Favorite